NDP52 mediates an antiviral response to hepatitis B virus infection through Rab9-dependent lysosomal degradation pathwayShuzhi Cui, Yu Wei|Nature Communications|2023Cited by 21
CDC42 supports HBV entry by NTCP translocation to the plasma membrane and macropinocytosisShuzhi Cui, Yaming Jiu|EMBO Reports|2025Cited by 2
NDP52 mediates an antiviral response to hepatitis B virus infection through Rab9-dependent lysosomal degradation pathwayShuzhi Cui, Yu Wei|Research Square|2023Cited by 1